{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:44:31Z","timestamp":1792032271200,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lower socioeconomic status conveys a known survival disadvantage for patients with esophageal adenocarcinoma (EAC). The potential role of the treating center volume in mitigating this disparity has not been described to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Non-metastatic EAC patients were identified (NCDB 2012\u20132021). High- and low-risk zip code groups were derived from income and education quartiles. Center volume was delineated as \u201clow\u201d or \u201chigh,\u201d with an annual threshold of \u2265\u200910 esophagectomies. Standard chi-square modeling, multivariable Cox hazard regression models, and Kaplan-Meier survival analyses were used where appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 7462 EAC patients, 38.2% (\n                      <jats:italic>n<\/jats:italic>\n                      = 2849) resided in high-risk zip code areas, and 87.1% were treated at low-volume centers. Clinical (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.230) and pathologic (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.992) staging distribution did not differ across zip codes. High-volume centers saw a slightly increased proportion of advanced disease (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). Patients at high-volume centers experienced better survival (5-year overall survival [5yOS], 44.97%) than their low-volume counterparts (5yOS, 40.62%) (\n                      <jats:italic>p &lt;<\/jats:italic>\n                      0.001). Patients residing in high-risk zip code areas demonstrated worse 5yOS than their low-risk counterparts (38.20% vs 43.74%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Evaluation of low-volume centers showed that the high-risk zip code group had shorter survival than their low-risk counterparts (36.80% vs 43.21%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Interestingly, in high-volume centers, survival across zip code groups was notably comparable (45.69% vs 46.20%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.80).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Center expertise may offer an avenue for mitigating sociodemographic survival disparities in esophageal cancer. As discussions regarding centralized oncologic care continue, particular attention should be paid to the impact of high-volume center referral on the treatment of patients with social risk factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20452-3","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:52:39Z","timestamp":1792029159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Where You Live and Where You Are Treated: Addressing Disparities in Esophageal Adenocarcinoma"],"prefix":"10.1245","author":[{"given":"Megan E.","family":"Campany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Welton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Linsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinny S.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-5453","authenticated-orcid":false,"given":"Britton B.","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"20452_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41416-021-01485-9","volume":"126","author":"JC Bolger","year":"2022","unstructured":"Bolger JC, Donohoe CL, Lowery M, Reynolds JV. Advances in the curative management of oesophageal cancer. Br J Cancer. 2022;126:706\u201317. https:\/\/doi.org\/10.1038\/s41416-021-01485-9.","journal-title":"Br J Cancer."},{"key":"20452_CR2","unstructured":"National Cancer Institute. Cancer stat facts: esophageal cancer. Surveillance, Epidemiology, and End Results (SEER) Program. Received 11 June 2026 at https:\/\/seer.cancer.gov\/statfacts\/html\/esoph.html."},{"key":"20452_CR3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.athoracsur.2021.07.092","volume":"114","author":"AH Adhia","year":"2022","unstructured":"Adhia AH, Feinglass JM, Schlick CJR, Merkow RP, Bilimoria KY, Odell DD. Hospital volume predicts guideline-concordant care in stage III esophageal cancer. Ann Thorac Surg. 2022;114:1176\u201382. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.07.092.","journal-title":"Ann Thorac Surg."},{"key":"20452_CR4","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.jtcvs.2021.05.048","volume":"163","author":"DC Patel","year":"2022","unstructured":"Patel DC, Jeffrey Yang CF, He H, et al. Influence of facility volume on long-term survival of patients undergoing esophagectomy for esophageal cancer. J Thorac Cardiovasc Surg. 2022;163:1536-1546.e3. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.05.048.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"20452_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamasurg.2025.0018","volume":"160","author":"K Li","year":"2025","unstructured":"Li K, Yang X, Huang Y. Travel to high-volume centers and esophageal cancer. JAMA Surg. 2025;160:600\u20131. https:\/\/doi.org\/10.1001\/jamasurg.2025.0018.","journal-title":"JAMA Surg."},{"key":"20452_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/SLA.0000000000005681","volume":"278","author":"KE Rhodin","year":"2023","unstructured":"Rhodin KE, Raman V, Jensen CW, et al. The effect of center esophagectomy volume on outcomes in clinical stage I to III esophageal cancer. Ann Surg. 2023;278:79\u201386. https:\/\/doi.org\/10.1097\/SLA.0000000000005681.","journal-title":"Ann Surg."},{"key":"20452_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.surg.2004.03.004","volume":"135","author":"JD Birkmeyer","year":"2004","unstructured":"Birkmeyer JD, Dimick JB. Potential benefits of the new Leapfrog standards: effect of process and outcomes measures. Surgery. 2004;135:569\u201375. https:\/\/doi.org\/10.1016\/j.surg.2004.03.004.","journal-title":"Surgery."},{"key":"20452_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s12885-023-11445-6","volume":"23","author":"C Arditi","year":"2023","unstructured":"Arditi C, Eicher M, Junod J, Peytremann-Bridevaux I. Socio-demographic and health-related determinants of patients\u2019 overall rating and experiences of cancer care. BMC Cancer. 2023;23:918. https:\/\/doi.org\/10.1186\/s12885-023-11445-6.","journal-title":"BMC Cancer."},{"key":"20452_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s11605-020-04653-z","volume":"25","author":"SL Savitch","year":"2021","unstructured":"Savitch SL, Grenda TR, Scott W, et al. Racial disparities in rates of surgery for esophageal cancer: a study from the National Cancer Database. J Gastrointest Surg. 2021;25:581\u201392. https:\/\/doi.org\/10.1007\/s11605-020-04653-z.","journal-title":"J Gastrointest Surg."},{"key":"20452_CR10","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.21037\/jtd-2025-637","volume":"17","author":"ME Campany","year":"2025","unstructured":"Campany ME, Kim S, Beamer SE, et al. The impact of high-risk zip code on receiving standard of care therapy and survival in esophageal adenocarcinoma. J Thorac Dis. 2025;17:6724\u201334. https:\/\/doi.org\/10.21037\/jtd-2025-637.","journal-title":"J Thorac Dis."},{"key":"20452_CR11","doi-asserted-by":"publisher","first-page":"e249474","DOI":"10.1001\/jamanetworkopen.2024.9474","volume":"7","author":"MR Desjardins","year":"2024","unstructured":"Desjardins MR, Kanarek NF, Nelson WG, Bachman J, Curriero FC. Disparities in cancer stage outcomes by catchment areas for a comprehensive cancer center. JAMA Netw Open. 2024;7:e249474. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.9474.","journal-title":"JAMA Netw Open."},{"key":"20452_CR12","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1634\/theoncologist.2015-0110","volume":"20","author":"M Ambroggi","year":"2015","unstructured":"Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L. Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist. 2015;20:1378\u201385. https:\/\/doi.org\/10.1634\/theoncologist.2015-0110.","journal-title":"Oncologist."},{"key":"20452_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/MLR.0000000000000716","volume":"55","author":"SN Smith","year":"2017","unstructured":"Smith SN, Reichert H, Ameling J, Meddings J. Dissecting Leapfrog: how well do Leapfrog safe practices scores correlate with hospital compare ratings and penalties, and how much do they matter? Med Care. 2017;55:606\u201314. https:\/\/doi.org\/10.1097\/MLR.0000000000000716.","journal-title":"Med Care."},{"key":"20452_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.athoracsur.2010.11.006","volume":"91","author":"TK Varghese","year":"2011","unstructured":"Varghese TK, Wood DE, Farjah F, et al. Variation in esophagectomy outcomes in hospitals meeting Leapfrog volume outcome standards. Ann Thorac Surg. 2011;91:1003\u201310. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.11.006.","journal-title":"Ann Thorac Surg."},{"key":"20452_CR15","doi-asserted-by":"publisher","first-page":"e203942","DOI":"10.1001\/jamanetworkopen.2020.3942","volume":"3","author":"DJ Boffa","year":"2020","unstructured":"Boffa DJ, Mallin K, Herrin J, et al. Survival after cancer treatment at top-ranked US cancer hospitals vs affiliates of top-ranked cancer hospitals. JAMA Netw Open. 2020;3:e203942. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3942.","journal-title":"JAMA Netw Open."},{"key":"20452_CR16","doi-asserted-by":"publisher","first-page":"e191912","DOI":"10.1001\/jamanetworkopen.2019.1912","volume":"2","author":"JR Hoag","year":"2019","unstructured":"Hoag JR, Resio BJ, Monsalve AF, et al. Differential safety between top-ranked cancer hospitals and their affiliates for complex cancer surgery. JAMA Netw Open. 2019;2:e191912. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.1912.","journal-title":"JAMA Netw Open."},{"key":"20452_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/oncolo\/oyac069","volume":"27","author":"JA Marks","year":"2022","unstructured":"Marks JA, Switchenko JM, Martini DJ, et al. Developing a virtual equity hub: adapting the tumor board model for equity in cancer care. Oncologist. 2022;27:518\u201324. https:\/\/doi.org\/10.1093\/oncolo\/oyac069.","journal-title":"Oncologist."},{"key":"20452_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1200\/EDBK_100026","volume":"41","author":"N Dixit","year":"2021","unstructured":"Dixit N, Rugo H, Burke NJ. Navigating a path to equity in cancer care: the role of patient navigation. Am Soc Clin Oncol Educ Book. 2021;41:3\u201310. https:\/\/doi.org\/10.1200\/EDBK_100026.","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"20452_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.surg.2017.08.026","volume":"163","author":"J Vu","year":"2018","unstructured":"Vu J, Englesbe M, Sheetz K. Databases for surgical health services research: collaborative quality improvement programs. Surgery. 2018;163:837\u20139. https:\/\/doi.org\/10.1016\/j.surg.2017.08.026.","journal-title":"Surgery."},{"key":"20452_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1001\/archsurg.2010.220","volume":"145","author":"DA Campbell Jr","year":"2010","unstructured":"Campbell DA Jr, Englesbe MJ, Kubus JJ, et al. Accelerating the pace of surgical quality improvement: the power of hospital collaboration. Arch Surg. 2010;145:985\u201391. https:\/\/doi.org\/10.1001\/archsurg.2010.220.","journal-title":"Arch Surg."},{"key":"20452_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/CEH.0000000000000172","volume":"37","author":"S Arora","year":"2017","unstructured":"Arora S, Kalishman SG, Thornton KA, Komaromy MS, Katzman JG, Struminger BB, et al. Project ECHO: a telementoring network model for continuing professional development. J Contin Educ Health Prof. 2017;37:239\u201344. https:\/\/doi.org\/10.1097\/CEH.0000000000000172.","journal-title":"J Contin Educ Health Prof."},{"key":"20452_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/SLA.0000000000001071","volume":"261","author":"A Mehrotra","year":"2015","unstructured":"Mehrotra A, Dimick JB. Ensuring excellence in centers of excellence programs. Ann Surg. 2015;261:237\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000001071.","journal-title":"Ann Surg."},{"key":"20452_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1245\/s10434-008-0098-5","volume":"16","author":"JD Birkmeyer","year":"2009","unstructured":"Birkmeyer JD. Improving outcomes with lung cancer surgery: selective referral or quality improvement? Ann Surg Oncol. 2009;16:1\u20132. https:\/\/doi.org\/10.1245\/s10434-008-0098-5.","journal-title":"Ann Surg Oncol."},{"key":"20452_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa2409408","volume":"392","author":"J Hoeppner","year":"2025","unstructured":"Hoeppner J, Lordick F, Brunner T, et al. Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer. N Engl J Med. 2025;392:323\u201335. https:\/\/doi.org\/10.1056\/NEJMoa2409408.","journal-title":"N Engl J Med."},{"key":"20452_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2503701","volume":"393","author":"YY Janjigian","year":"2025","unstructured":"Janjigian YY, Al-Batran SE, Wainberg ZA, et al. Perioperative durvalumab in gastric and gastroesophageal junction cancer. N Engl J Med. 2025;393:217\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2503701.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20452-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20452-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20452-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:52:41Z","timestamp":1792029161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20452-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":25,"alternative-id":["20452"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20452-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no disclosures relevant to the topic of this manuscript.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}